Cargando…
Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation
Cholangiocarcinoma (CCA) is a complex and refractor type of cancer with global prevalence. Several barriers remain in CCA diagnosis, treatment, and prognosis. Therefore, exploring more biomarkers and therapeutic drugs for CCA management is necessary. CCA gene expression data was downloaded from the...
Autores principales: | Wang, Jiena, Zhu, Weiwei, Tu, Junxue, Zheng, Yihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Microbiology and Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668091/ https://www.ncbi.nlm.nih.gov/pubmed/36224755 http://dx.doi.org/10.4014/jmb.2207.07037 |
Ejemplares similares
-
Discovery of Anticancer Activity of Amentoflavone on Esophageal Squamous Cell Carcinoma: Bioinformatics, Structure-Based Virtual Screening, and Biological Evaluation
por: Chen, Lei, et al.
Publicado: (2022) -
Bioinformatics combined with quantitative proteomics analyses and identification of potential biomarkers in cholangiocarcinoma
por: Da, Zijian, et al.
Publicado: (2020) -
Screening and identification of key biomarkers of depression using bioinformatics
por: Kong, Xinru, et al.
Publicado: (2023) -
Screening and identification of key genes between liver hepatocellular carcinoma (LIHC) and cholangiocarcinoma (CHOL) by bioinformatic analysis
por: Kang, Xindan, et al.
Publicado: (2020) -
Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma
por: Sungwan, Prin, et al.
Publicado: (2021)